| ID | dbAMP22099 |
|---|---|
| Sequence | VNWKKIILGKIIKVVK |
| Length | 16 |
| Name | LL-III/11&&Lasioglossin LL-III/11&&Lasioglossin III and its analogs |
| Source | Lasioglossin III and its analogs |
| Activity | Antibacterial |
| Pathogen | Leukemia Cancer (IC50 = 4±1 µM)&&Colon Cancer (IC50 = 48 µM)&&Cervical Cancer (IC50 = 8±1 µM) |
| Hemolytic Activity | Not included yet |
| Cytotoxicity | Not included yet |
| N-terminal Modification | Not included yet |
| C-terminal Modification | Not included yet |
| Linear/Cyclic/Branched | Not included yet |
| Uniprot | |
| PDB | |
| 3D View | |
| PDB Download | Download PDB Predicted by Alphafold2 |
| PubMed ID | 22100226, 22100226, 22100226 |
Physicochemical Properties
| Residues | 16 |
|---|---|
| Sequence | VNWKKIILGKIIKVVK |
| Molecular Weight | 1879.422 |
| Grand Average of Hydropathy | 0.631 |
| Isoelectric Point | 10.602 |
| Charge at pH 7.4 | 4.511 |
| Secondary Structure | Helix: 0.562, Turn: 0.125, Sheet: 0.062 |
| Instability Index | -13.4 |
| Aromaticity | 0.062 |